167 related articles for article (PubMed ID: 25779575)
1. Squalestatin is an inhibitor of carotenoid biosynthesis in Plasmodium falciparum.
Gabriel HB; Silva MF; Kimura EA; Wunderlich G; Katzin AM; Azevedo MF
Antimicrob Agents Chemother; 2015; 59(6):3180-8. PubMed ID: 25779575
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Antimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway.
da Silva MF; Saito AY; Peres VJ; Oliveira AC; Katzin AM
Antimicrob Agents Chemother; 2015 Aug; 59(8):5084-7. PubMed ID: 26055383
[TBL] [Abstract][Full Text] [Related]
3. Exploiting a basic chemosensitizing pharmacophore hypothesis. Part 1: synthesis and biological evaluation of novel arylbromide and bicyclic chemosensitizers against drug-resistant malaria parasites.
Chouteau F; Ramanitrahasimbola D; Rasoanaivo P; Chibale K
Bioorg Med Chem Lett; 2005 Jun; 15(12):3024-8. PubMed ID: 15908208
[TBL] [Abstract][Full Text] [Related]
4. Carotenoid biosynthesis in intraerythrocytic stages of Plasmodium falciparum.
Tonhosolo R; D'Alexandri FL; de Rosso VV; Gazarini ML; Matsumura MY; Peres VJ; Merino EF; Carlton JM; Wunderlich G; Mercadante AZ; Kimura EA; Katzin AM
J Biol Chem; 2009 Apr; 284(15):9974-85. PubMed ID: 19203994
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into a key carotenogenesis related enzyme phytoene synthase of P. falciparum: a novel drug target for malaria.
Agarwal S; Sharma V; Phulera S; Abdin MZ; Ayana R; Singh S
Syst Synth Biol; 2015 Dec; 9(Suppl 1):27-37. PubMed ID: 26702306
[TBL] [Abstract][Full Text] [Related]
6. Salinipostins A-K, long-chain bicyclic phosphotriesters as a potent and selective antimalarial chemotype.
Schulze CJ; Navarro G; Ebert D; DeRisi J; Linington RG
J Org Chem; 2015 Feb; 80(3):1312-20. PubMed ID: 25584395
[TBL] [Abstract][Full Text] [Related]
7. The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites.
Yoo E; Schulze CJ; Stokes BH; Onguka O; Yeo T; Mok S; Gnädig NF; Zhou Y; Kurita K; Foe IT; Terrell SM; Boucher MJ; Cieplak P; Kumpornsin K; Lee MCS; Linington RG; Long JZ; Uhlemann AC; Weerapana E; Fidock DA; Bogyo M
Cell Chem Biol; 2020 Feb; 27(2):143-157.e5. PubMed ID: 31978322
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates.
Basco LK; Dechy-Cabaret O; Ndounga M; Meche FS; Robert A; Meunier B
Antimicrob Agents Chemother; 2001 Jun; 45(6):1886-8. PubMed ID: 11353644
[TBL] [Abstract][Full Text] [Related]
9. Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum.
Sharma V; Agarwal S; Madurkar SM; Datta G; Dangi P; Dandugudumula R; Sen S; Singh S
Malar J; 2014 Nov; 13():467. PubMed ID: 25431142
[TBL] [Abstract][Full Text] [Related]
10. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation.
Posner GH; Cumming JN; Woo SH; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1998 Mar; 41(6):940-51. PubMed ID: 9526568
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity.
Varghese S; Rahmani R; Drew DR; Beeson JG; Baum J; Smith BJ; Baell JB
ChemMedChem; 2021 Feb; 16(4):679-693. PubMed ID: 32929894
[TBL] [Abstract][Full Text] [Related]
12. Anthracene-polyamine conjugates inhibit in vitro proliferation of intraerythrocytic Plasmodium falciparum parasites.
Niemand J; Burger P; Verlinden BK; Reader J; Joubert AM; Kaiser A; Louw AI; Kirk K; Phanstiel O; Birkholtz LM
Antimicrob Agents Chemother; 2013 Jun; 57(6):2874-7. PubMed ID: 23545535
[TBL] [Abstract][Full Text] [Related]
13. Target identification and validation of novel antimalarials.
McNamara C; Winzeler EA
Future Microbiol; 2011 Jun; 6(6):693-704. PubMed ID: 21707315
[TBL] [Abstract][Full Text] [Related]
14. The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase.
Ittarat I; Asawamahasakda W; Meshnick SR
Exp Parasitol; 1994 Aug; 79(1):50-6. PubMed ID: 8050525
[TBL] [Abstract][Full Text] [Related]
15. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
[TBL] [Abstract][Full Text] [Related]
16. Arabidopsis OR proteins are the major posttranscriptional regulators of phytoene synthase in controlling carotenoid biosynthesis.
Zhou X; Welsch R; Yang Y; Álvarez D; Riediger M; Yuan H; Fish T; Liu J; Thannhauser TW; Li L
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3558-63. PubMed ID: 25675505
[TBL] [Abstract][Full Text] [Related]
17. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
Biot C; Dessolin J; Grellier P; Davioud-Charvet E
Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
[TBL] [Abstract][Full Text] [Related]
18. Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
Zhang YK; Plattner JJ; Freund YR; Easom EE; Zhou Y; Ye L; Zhou H; Waterson D; Gamo FJ; Sanz LM; Ge M; Li Z; Li L; Wang H; Cui H
Bioorg Med Chem Lett; 2012 Feb; 22(3):1299-307. PubMed ID: 22243961
[TBL] [Abstract][Full Text] [Related]
19. Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.
Chugh M; Scheurer C; Sax S; Bilsland E; van Schalkwyk DA; Wicht KJ; Hofmann N; Sharma A; Bashyam S; Singh S; Oliver SG; Egan TJ; Malhotra P; Sutherland CJ; Beck HP; Wittlin S; Spangenberg T; Ding XC
Antimicrob Agents Chemother; 2015 Feb; 59(2):1110-8. PubMed ID: 25487796
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
